Why the study?
Does BQ-123 reduce blood pressure in rat models of hypertension?
Population
Conscious, unrestrained spontaneously hypertensive rats, normotensive Wistar-Kyoto rats and renin…
Design
Preclinical
Follow-up
up to 14 h after cessation of infusion
Authors
Loading...
Endothelin A antagonism merits further hypertension research; animal data leave clinical translation unresolved.
Does BQ-123 reduce blood pressure in rat models of hypertension?
The selective endothelin subtype A-receptor antagonist BQ-123 lowers blood pressure in hypertensive rat models, highlighting the role of endothelin in hypertension.
Douglas et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: